CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Grant or award Director acquired 13,700 shares (grant or award)
- 4 Option exercise CEO and President acquired 287,000 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Grant or award CCO acquired 25,000 shares (grant or award)
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Results of operations · Executive or director change
- CT ORDER Other Confidential Order
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 4 Returned to the company SVP, Chief Medical Officer returned 4,409 shares (to the company)
- 4 Returned to the company SVP, Chief Business Officer returned 11,909 shares (to the company)
- 4 Returned to the company SVP, CLO & Secretary returned 11,929 shares (to the company)
- 4 Returned to the company SVP, Chief Development Officer returned 6,075 shares (to the company)
- 4 Returned to the company SVP, CFO & Treasurer returned 13,148 shares (to the company)
- 8-K Event Material agreement
Page 25 of 45 · 886 filings